Hikma Pharmaceuticals (HKMPF) announces the approval of KLOXXADO Nasal Spray 8 mg, by Health Canada for the treatment of known or suspected ...

KLOXXADO ® delivers 8 mg of naloxone hydrochloride per spray in a ready to use nasal spray to reverse the effects of opioid overdose.

Nasal spray shows preclinical promise for treating traumatic brain injury. ScienceDaily . Retrieved March 18, 2025 from www.sciencedaily.com / releases / 2025 / 02 / 250227125519.htm ...

The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic ...

The FDA has approved Neffy, a needle-free nasal spray, for children aged 4 and up, providing fast and effective treatment for ...

Nasal anti-CD3 spray reduces traumatic brain injury in mice, a potential breakthrough for TBI treatment. Read now.

Are you using your nasal spray correctly? 🤔 A doctor explains the best technique to ensure you're getting the most out of every spray! From proper positioning to common mistakes that could be ...

A nighttime nasal spray may offer a new way to ease sleep apnea and lower blood pressure, according to Australian researchers ...

CINCINNATI (WKRC) - The Food and Drug Administration issued a recall for certain nasal spray that tested positive for a bacterial contaminate that could lead to "potentially life-threatening ...

Neffy 1 mg is now approved by the FDA to treat pediatric patients who weigh 33 to 65 lbs. Neffy was first FDA-approved as a 2 ...

However, MGP Ingredients' earnings easily cover the dividend. This means that most of its earnings are being retained to grow the business. The next year is set to see EPS grow by 106.1%.

MGP (MGPI) came out with quarterly earnings of $1.57 per share, beating the Zacks Consensus Estimate of $1.49 per share. This compares to earnings of $1.64 per share a year ago. These figures are ...